(S)-α-Methylbenzyl Ricinoleamide is a fatty acid amide. (S)-α-Methylbenzyl Ricinoleamide shows antiproliferative activity, inhibits the growth of human ovarian cancer cells NCI-ADR/RES and glioma cells U251 with GI50s of 1.9 μg/mL and 3.6 μg/mL, respectively.